Small-molecule inhibitors/modulators of amyloid-β peptide aggregation and toxicity for the treatment of Alzheimer's disease: a patent review (2010 – 2012)

By Belluti Federica   Rampa Angela   Gobbi Silvia   Bisi Alessandra  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 5, 2013-05 ,pp. : 581-596

Informa Healthcare

Access to resources Recommend Favorite

β-Amyloid peptide as a target for treatment of Alzheimer’s disease

By Conde Santiago  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 4, 2002-04 ,pp. : 503-512

Informa Healthcare

Access to resources Recommend Favorite

beta-Amyloid Aggregation Inhibitors for the Treatment of Alzheimer Disease Dream or Reality?

By  

Mini Reviews in Medicinal Chemistry, Vol. 1, Iss. 2, 2001-07 ,pp. : 175-186

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetes

By Bak Ann Mosegaard   Egefjord Lærke   Gejl Michael   Steffensen Charlotte   Stecher Chalotte Willemann   Smidt Kamille   Brock Birgitte   Rungby Jørgen  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 10, 2011-10 ,pp. : 1153-1162

Informa Healthcare

Access to resources Recommend Favorite

Pyroglutamate-Modified Amyloid Beta Peptides: Emerging Targets for Alzheimer´s Disease Immunotherapy

By  

Current Neuropharmacology, Vol. 11, Iss. 5, 2013-09 ,pp. : 491-498

Bentham Science Publishers

Access to resources Recommend Favorite